Discontinued — last reported Q4 '21
Business Segments · Goodwill
Global Peripheral Interventions (PI) Reporting Unit — Goodwill
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ3 2020
Last reportedQ4 2021
Rolls up toGoodwill
How to read this metric
An increase typically reflects recent strategic acquisitions within the peripheral vascular space, while a decrease may indicate asset impairment charges or divestitures. Significant write-downs signal that the segment's future earnings potential has declined relative to the original acquisition price.
Detailed definition
This metric represents the carrying value of goodwill associated with the Peripheral Interventions reporting unit, which...
Peer comparison
Comparable to goodwill balances reported by medical device peers in the interventional cardiology or vascular surgery segments, often evaluated relative to the segment's total invested capital.
Metric ID:
bsx_segment_global_peripheral_interventions_pi_reporting_unit_goodwillHistorical Data
1 periods
| Q4 '21 | |
|---|---|
| Value | $1.40B |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's global peripheral interventions (pi) reporting unit — goodwill?
- Boston Scientific (BSX) reported global peripheral interventions (pi) reporting unit — goodwill of $1.40B in Q4 2021.
- What does global peripheral interventions (pi) reporting unit — goodwill mean?
- The recorded value of intangible assets like brand reputation and customer relationships acquired through past business acquisitions within the Peripheral Interventions segment.